0001104659-23-119962.txt : 20231120 0001104659-23-119962.hdr.sgml : 20231120 20231120170007 ACCESSION NUMBER: 0001104659-23-119962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEWHALL CHARLES W III CENTRAL INDEX KEY: 0001005544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 231423454 MAIL ADDRESS: STREET 1: 1119 ST PAUL ST CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm2331055-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-16 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001005544 NEWHALL CHARLES W III C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 1 0 0 0 0 Common Stock 2023-11-16 4 M 0 7457 9.24 A 119589 D Common Stock 2023-11-16 4 S 0 2500 28.01 D 117089 D Director Stock Option (Right to Buy) 9.24 2023-11-16 4 M 0 7457 0 D 2015-01-21 2024-01-21 Common Stock 7457 0 D Represents the number of shares of common stock sold to cover the exercise price of the employee stock options. /s/ Timothy C. Dec, as attorney-in-fact 2023-11-20